Low incidence of MDR1 expression in acute promyelocytic leukaemia
- 1 June 1995
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 90 (2) , 369-374
- https://doi.org/10.1111/j.1365-2141.1995.tb05161.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cellsBlood, 1993
- Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype [see comments]Blood, 1992
- Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]Blood, 1992
- Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis [see comments]Blood, 1992
- Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivityBlood, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patientsBlood, 1988
- Acute myelogenous leukemia: recent advances in therapyBlood, 1987